LOM
JAZZ icon

Loeb Offshore Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Loeb Offshore Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-2,673
Closed -$246K – 210
2013
Q3 		$246K Buy
+2,673
New +$216K 0.08% 175

Other funds holding JAZZ

PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
WBC
Westpac Banking Corp Sydney, Australia $1.44B AUM 28.5% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Loeb Offshore Management's JAZZ Position: Q4 2013 in Review

Loeb Offshore Management sold out of Jazz Pharmaceuticals (JAZZ) in Q4 2013, closing a stake of 2,673 shares — an estimated $246K sold.

Loeb Offshore Management first reported a position in JAZZ in Q3 2013 and held it in 1 quarter. The position peaked at $246K in Q3 2013. 280 funds tracked by Wall St. Rank hold JAZZ as of Q4 2013.

  • Loeb Offshore Management reported no remaining Jazz Pharmaceuticals position as of Q4 2013 after selling out during the quarter.
  • Loeb Offshore Management sold 2,673 Jazz Pharmaceuticals shares in Q4 2013, an estimated $246K.
  • Loeb Offshore Management first reported a position in Jazz Pharmaceuticals in Q3 2013 and held it in 1 quarter.
  • Loeb Offshore Management's Jazz Pharmaceuticals position peaked at $246K in Q3 2013.
  • 280 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2013.

Based on Loeb Offshore Management's 13F filing for Q4 2013, filed 14 Feb 2014.